The mutational landscape of hepatocellular carcinoma.
10.3350/cmh.2015.21.3.220
- Author:
Ju Seog LEE
1
Author Information
1. Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jlee@mdanderson.org
- Publication Type:Research Support, Non-U.S. Gov't ; Review
- Keywords:
Hepatocellular carcinoma;
Cancer genomics;
Somatic mutations;
TERT;
TP53
- MeSH:
Carcinoma, Hepatocellular/*pathology/therapy;
Humans;
Intracellular Signaling Peptides and Proteins/metabolism;
Liver Neoplasms/*pathology/therapy;
Mutation;
Oxidative Stress;
Precision Medicine;
Telomerase/metabolism;
Transcription Factors/genetics/metabolism;
Tumor Suppressor Protein p53/genetics/metabolism
- From:Clinical and Molecular Hepatology
2015;21(3):220-229
- CountryRepublic of Korea
- Language:English
-
Abstract:
The development of hepatocellular carcinoma (HCC) is a complex process, and HCC arises from the accumulation of multiple genetic alterations leading to changes in the genomic landscape. Current advances in genomic technologies have revolutionized the search for genetic alterations in cancer genomes. Recent studies in which all coding exons in HCC were sequenced have shed new light on the genomic landscape of this malignant disease. Catalogues of these somatic mutations and systematic analysis of catalogued mutations will lead us to uncover candidate HCC driver genes, although further functional validation is needed to determine whether these genes play a causal role in the development of HCC. This review provides an overview of previously known oncogenes and new oncogene candidates in HCC that were uncovered from recent exome or whole-genome sequencing studies. This knowledge provides direction for future personalized treatment approaches for patients with HCC.
